| Name |
Recombinant Cynomolgus Monkey B7-1/CD80 Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9244-B1
|
| Category |
Protein
|
| Prices |
$339.00
|
| Sizes |
100 µg
|
| Species Reactivities |
Monkey
|
| Nature |
Recombinant
|
| Source |
Human embryonic kidney cell, HEK293-derived Val35-Asn242, with a C-terminal 6-His tag
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Cynomolgus Monkey B7-1/CD80 is immobilized at 0.5 µg/mL (100 µL/well), the concentration of Recombinant Human CTLA-4 Fc Chimera (Catalog # 7268-CT ) that produces 50% of the optimal binding response is approximately 5-30 ng/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
XP_005548122
|
| Gene |
CD80
|
| Sequence |
Val35
|
| Supplier Page |
Shop
|
When Recombinant Cynomolgus Monkey B7-1/CD80 (Catalog # 9244-B1) is immobilized at 0.5 µg/mL (100 µL/well), Recombinant Human CTLA-4 Fc Chimera (Catalog # 7268-CT ) binds with an ED 50 of 5-30 ng/mL.